SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE900.30-0.25 (-0.03 %)
PREV CLOSE () 900.55
OPEN PRICE () 899.00
BID PRICE (QTY) 899.85 (1)
OFFER PRICE (QTY) 900.40 (1)
VOLUME 33313
TODAY'S LOW / HIGH ()896.00 912.25
52 WK LOW / HIGH ()652.75 966.9
NSE900.000.05 (+0.01 %)
PREV CLOSE() 899.95
OPEN PRICE () 901.95
BID PRICE (QTY) 900.00 (203)
OFFER PRICE (QTY) 900.05 (39)
VOLUME 1155891
TODAY'S LOW / HIGH() 896.00 912.80
52 WK LOW / HIGH ()652.7 967.05
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Israel Makov - Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details :

Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
27May Sun Pharma’s arm acquires Uractiv Port
Sun Pharmaceutical Industries’ subsidiary -- S.C. Terapia S.A., Romania..
27May Sun Pharma trades higher as its arm ac
Sun Pharmaceutical Industries is currently trading at Rs. 907.00, up by..
23May Sun Pharmaceutical Industries’ US arm
Sun Pharmaceutical Industries’ US subsidiary is recalling 10,548 bottles..
19May Sun Pharma, Adani Enterprises and Endu
Sun Pharmaceutical Industries’ one of wholly-owned subsidiaries is plann..
19May Sun Pharmaceutical Industries informs
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
Financials
in Millions
QTR Dec 21 ANNUAL 21
Net Profit5154.321397
Gross Profit 5209.1 21528.7
Operating Profit 9616.230862.2
Net Sales 37706.6128032.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 2895.25 (9.28%)
M.Cap ( in Cr)
7227.50
JB Chem & Pharma (BSE)
 1624.00 (3.92%)
M.Cap ( in Cr)
12200.52
NGL Fine-Chem (BSE)
 1864.60 (3.28%)
M.Cap ( in Cr)
1149.14
Neuland Laboratories (BSE)
 1022.15 (4.70%)
M.Cap ( in Cr)
1298.32
Alkem Laboratories (BSE)
 3064.70 (1.33%)
M.Cap ( in Cr)
36023.14
Shareholding Pattern
PROMOTERS 54.48%
MUTUAL FUNDS/UTI 11.63%
NON-INSTITUTION 11.06%
FI/BANKS/INSURANCE 8.31%
GOVERNMENT 0%
FII 0%
attention investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020.      2. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.      3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.      4. Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.     5. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.     6. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.     .......... Issued in the interest of Investors
Copyright © 2017 ExcelStock Broking Pvt. Ltd. All Rights Reserved
Designed , Developed & Content Powered by  Accord Fintech Pvt. Ltd.
close X

Download Client Registration Documents